Clinical Trial to Evaluate the Efficacy and Safety of YHP1701
Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine superiority of YHP1701 comparing to each
monotherapy in patient with hypertension and primary hypercholesterolemia.